These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

335 related articles for article (PubMed ID: 11756578)

  • 21. Plasma Epstein-Barr virus immunoglobulin A and DNA for nasopharyngeal carcinoma screening in the United States.
    O TM; Yu G; Hu K; Li JC
    Otolaryngol Head Neck Surg; 2007 Jun; 136(6):992-7. PubMed ID: 17547994
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antibodies to Epstein-Barr virus in nasopharyngeal carcinoma, tonsillar carcinoma and control groups.
    Oberender H; Nowak R; Donner A; Kunkel M; Gärtner L; Scholtz HJ
    Acta Virol; 1983 May; 27(3):277-81. PubMed ID: 6138990
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [The clinical usefulness of the serological study of IgG antibodies and IgA against the antigens associated with the Epstein-Barr virus in patients with nasopharyngeal carcinoma].
    Amador García JM; Mendoza Montero J; Expósito Hernández J; Salinero Hernández J; Esquivias López-Cuerpo J; Ballesteros García P
    Acta Otorrinolaringol Esp; 1992; 43(1):31-6. PubMed ID: 1316136
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Demonstration of IgG- and IgA-antibodies against Epstein-Barr virus-associated antigens with a microtiter enzyme immunoassay system. The determination of serum antibodies against the viral capsid antigen and the early antigen complex in the sera of tumor and infectious mononucleosis patients].
    Dölken G; Bitzer M; Bross KJ; Brugger W; Boldt C; Hirsch FW; Weitzmann U; Löhr GW
    Dtsch Med Wochenschr; 1984 Nov; 109(48):1837-43. PubMed ID: 6094138
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Combined determination of Epstein-Barr virus-related antibodies and antigens for diagnosis of nasopharyngeal carcinoma.
    Luo YL; Ou GP; Chi PD; Liang YN; Liu YH; Huang MY
    Ai Zheng; 2009 Jan; 28(1):76-8. PubMed ID: 19448423
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Activation of maternal Epstein-Barr virus infection and risk of acute leukemia in the offspring.
    Tedeschi R; Bloigu A; Ogmundsdottir HM; Marus A; Dillner J; dePaoli P; Gudnadottir M; Koskela P; Pukkala E; Lehtinen T; Lehtinen M
    Am J Epidemiol; 2007 Jan; 165(2):134-7. PubMed ID: 17005627
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [IgG and IgA antibodies to the Epstein-Barr virus and nasopharyngeal carcinoma].
    Vera Sempere FJ
    Med Clin (Barc); 1992 May; 98(19):758-9. PubMed ID: 1318986
    [No Abstract]   [Full Text] [Related]  

  • 28. Seroreactivity against Epstein-Barr virus (EBV) among first-degree relatives of sporadic EBV-associated nasopharyngeal carcinoma in Indonesia.
    Hutajulu SH; Ng N; Jati BR; Fachiroh J; Herdini C; Hariwiyanto B; Haryana SM; Middeldorp JM
    J Med Virol; 2012 May; 84(5):768-76. PubMed ID: 22431025
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [The purification and application of Epstein-Barr virus gp125].
    Wang G; Pi G; Gu S
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 1998 Jun; 12(2):143-6. PubMed ID: 12515193
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Elevated Epstein-Barr virus antibodies in patients with Hodgkin's disease].
    Kuljić-Kapulica N
    Srp Arh Celok Lek; 1998; 126(3-4):97-100. PubMed ID: 9863363
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Evaluation of combined determinations of Epstein-Barr virus antibodies for nasopharyngeal carcinoma assessed with receiver operating characteristic curve based on logistic regression].
    Cai YL; Zheng YM; Cheng JR; Li J; Mo YK; Zhong QY
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2009 Oct; 23(5):384-7. PubMed ID: 20387494
    [TBL] [Abstract][Full Text] [Related]  

  • 32. EBV-specific humoral antibodies in nasopharyngeal carcinoma patients in Cuba.
    Ruiz R; Gurtsevich V; Le Riverend E
    Neoplasma; 1979; 26(2):125-31. PubMed ID: 224330
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Significance of cell-free Epstein-Barr virus DNA in monitoring prognosis of nasopharyngeal carcinoma].
    Cao SM; Min HQ; Gao JS; Hong MH; Xiao XB; Zhang CQ; Liu XD; Zhang AL; Guo X
    Ai Zheng; 2003 Mar; 22(3):302-6. PubMed ID: 12654192
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Nasopharyngeal carcinoma: the diagnostic value of the antibody-dependent, cellular cytotoxicity test and of EBV serology.
    Faggioni A; Corradini C; Venanzoni M; Cardi G; Bevere F; Barile G; Zompetta C; Frati L
    J Exp Pathol; 1987; 3(4):471-7. PubMed ID: 2842480
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Complementary serum test of antibodies to Epstein-Barr virus nuclear antigen-1 and early antigen: a possible alternative for primary screening of nasopharyngeal carcinoma.
    Chang KP; Hsu CL; Chang YL; Tsang NM; Chen CK; Lee TJ; Tsao KC; Huang CG; Chang YS; Yu JS; Hao SP
    Oral Oncol; 2008 Aug; 44(8):784-92. PubMed ID: 18206420
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Epstein-Barr virus serological markers for nasopharyngeal carcinoma in Thailand.
    Puthavathana P; Sutthent R; Vitavasiri A; Wasi C; Chantarakul N; Thongcharoen P
    Southeast Asian J Trop Med Public Health; 1991 Sep; 22(3):326-31. PubMed ID: 1818381
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Detection and analysis of anti-latent membrane protein 2A antibodies in the sera of patients with Epstein-Barr virus associated malignancies.
    Chen Y; Yao K; Sun H; Qing J; Peng GY
    Chin Med J (Engl); 2005 May; 118(9):725-30. PubMed ID: 15899133
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Immune responses to Epstein-Barr virus lytic proteins in patients with nasopharyngeal carcinoma.
    Liu MY; Huang YT; Sheen TS; Chen JY; Tsai CH
    J Med Virol; 2004 Aug; 73(4):574-82. PubMed ID: 15221902
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Epstein-Barr virus (EBV) serology for predicting distant metastases in a white juvenile patient with nasopharyngeal carcinoma and no clinical response to EBV lytic induction therapy.
    Stevens SJ; Zwaan CM; Verkuijlen SA; Middeldorp JM
    Head Neck; 2006 Nov; 28(11):1040-5. PubMed ID: 16933315
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Familial tendency and risk of nasopharyngeal carcinoma in taiwan: effects of covariates on risk.
    Hsu WL; Yu KJ; Chien YC; Chiang CJ; Cheng YJ; Chen JY; Liu MY; Chou SP; You SL; Hsu MM; Lou PJ; Wang CP; Hong JH; Leu YS; Tsai MH; Su MC; Tsai ST; Chao WY; Ger LP; Chen PR; Yang CS; Hildesheim A; Diehl SR; Chen CJ
    Am J Epidemiol; 2011 Feb; 173(3):292-9. PubMed ID: 21148719
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.